Calls for papers
-
Arch Biopartners has announced that Catalent Inhalation will begin the process of manufacturing its AB569 bactericidal inhalation solution for use in trials of the drug in patients with antibiotic resistant lung infections. The process will… Read more . . .
-
AstraZeneca has announced top-line results from the Phase 3 RISE (Revealing the Impact of Symbicort in reducing Exacerbations in COPD) and CHASE 3 (ChildHood Asthma Safety and Efficacy) studies of the Symbicort budesonide/formoterol fumarate MDI… Read more . . .
-
A Q&A with Kristian Debus and Prashanth Shankara of CD-adapco Q: Doesn’t optimization of drug delivery devices using computer simulation require a lot of time and resources? KD: Actually, these days you can optimize an… Read more . . .
-
Windtree Therapeutics has received $1 million from a Phase 2 Small Business Innovation Research Grant (SBIR) worth up to $2.6 million for a Phase 2b trial of its Aerosurf aerosolized KL4 surfactant in premature infants… Read more . . .
-
Dr. Reddy’s Laboratories has acquired tobramycin inhalation solution from Teva Pharmaceutical Industries as part of the divestiture required by the US Federal Trade Commission (FTC) before Teva could acquire Allergan’s generics business. Teva received FDA… Read more . . .
-
Adamis Pharmaceuticals says that it has received additional US and European patents for the Taper dry powder inhaler, which the company acquired from 3M Drug Delivery Systems in 2013. In January 2015, Adamis announced that… Read more . . .
-
GSK’s Veramyst fluticasone furoate nasal spray will soon be available as an over-the-counter product marketed as Flonase Sensimist, GSK Consumer Healthcare has announced. According to the company, the FDA has approved Flonase Sensimist as an… Read more . . .
-
Altimmune has announced that the US Biomedical Advanced Research and Development Authority (BARDA) has awarded the company a contract worth up to $120.2 million over five years for clinical development of NasoShield intranasal anthrax vaccine.… Read more . . .
-
US-based Cannabis Science has announced that it “will release an inhalation medication for those suffering asthma/COPD for use in patient nebulizers.” According to the company, the product would be available “in states where marijuana is… Read more . . .
-
According to Mast Therapeutics the first patient has been enrolled in a Phase 2 study of its AIR001 sodium nitrite inhalation solution in patients with heart failure with preserved ejection fraction (HFpEF). The multicenter, randomized,… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
October 19-October 20: MVIC Autumn Training 2026, Lund, Sweden
October 21-October 22: MVIC Symposium, Lund, Sweden
November 10-November 11: Rescon Europe 2026, Porto, Portugal
December 9-December 11: DDL 2026, Edinburgh, Scotland